239 related articles for article (PubMed ID: 25679211)
21. Tetraloop-like geometries could form the basis of the catalytic activity of the most ancient ribooligonucleotides.
Stadlbauer P; Šponer J; Costanzo G; Di Mauro E; Pino S; Šponer JE
Chemistry; 2015 Feb; 21(9):3596-604. PubMed ID: 25640446
[TBL] [Abstract][Full Text] [Related]
22. Construction of new ribozymes requiring short regulator oligonucleotides as a cofactor.
Komatsu Y; Yamashita S; Kazama N; Nobuoka K; Ohtsuka E
J Mol Biol; 2000 Jun; 299(5):1231-43. PubMed ID: 10873448
[TBL] [Abstract][Full Text] [Related]
23. PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules.
Egholm M; Buchardt O; Christensen L; Behrens C; Freier SM; Driver DA; Berg RH; Kim SK; Norden B; Nielsen PE
Nature; 1993 Oct; 365(6446):566-8. PubMed ID: 7692304
[TBL] [Abstract][Full Text] [Related]
24. Control of complexity constraints on combinatorial screening for preferred oligonucleotide hybridization sites on structured RNA.
Bruice TW; Lima WF
Biochemistry; 1997 Apr; 36(16):5004-19. PubMed ID: 9125523
[TBL] [Abstract][Full Text] [Related]
25. Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.
Vester B; Hansen LH; Lundberg LB; Babu BR; Sørensen MD; Wengel J; Douthwaite S
BMC Mol Biol; 2006 Jun; 7():19. PubMed ID: 16753066
[TBL] [Abstract][Full Text] [Related]
26. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
27. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
Jen KY; Gewirtz AM
Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
[TBL] [Abstract][Full Text] [Related]
28. [Effect of chirality of ribose on nucleic acid structure and function].
Urata H
Yakugaku Zasshi; 1999 Oct; 119(10):689-709. PubMed ID: 10518456
[TBL] [Abstract][Full Text] [Related]
29. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
30. Binding of short oligonucleotides to RNA: studies of the binding of common RNA structural motifs to isoenergetic microarrays.
Kierzek E
Biochemistry; 2009 Dec; 48(48):11344-56. PubMed ID: 19835418
[TBL] [Abstract][Full Text] [Related]
31. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
32. Mismatch formation in solution and on DNA microarrays: how modified nucleosides can overcome shortcomings of imperfect hybridization caused by oligonucleotide composition and base pairing.
Seela F; Budow S
Mol Biosyst; 2008 Mar; 4(3):232-45. PubMed ID: 18437266
[TBL] [Abstract][Full Text] [Related]
33. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
[TBL] [Abstract][Full Text] [Related]
34. Competitive regulation of modular allosteric aptazymes by a small molecule and oligonucleotide effector.
Najafi-Shoushtari SH; Famulok M
RNA; 2005 Oct; 11(10):1514-20. PubMed ID: 16199761
[TBL] [Abstract][Full Text] [Related]
35. Regulation of ribozyme cleavage activity by oligonucleotides.
Komatsu Y; Ohtsuka E
Methods Mol Biol; 2004; 252():165-77. PubMed ID: 15017048
[TBL] [Abstract][Full Text] [Related]
36. Oligonucleotide scanning of native mRNAs in extracts predicts intracellular ribozyme efficiency: ribozyme-mediated reduction of the murine DNA methyltransferase.
Scherr M; Reed M; Huang CF; Riggs AD; Rossi JJ
Mol Ther; 2000 Jul; 2(1):26-38. PubMed ID: 10899825
[TBL] [Abstract][Full Text] [Related]
37. Locked and unlocked nucleosides in functional nucleic acids.
Doessing H; Vester B
Molecules; 2011 May; 16(6):4511-26. PubMed ID: 21629180
[TBL] [Abstract][Full Text] [Related]
38. Nucleic acid based strategies as potential therapeutic tools: mechanistic considerations and implications to restenosis.
Santiago FS; Khachigian LM
J Mol Med (Berl); 2001 Dec; 79(12):695-706. PubMed ID: 11862313
[TBL] [Abstract][Full Text] [Related]
39. Oligonucleotides with Cationic Backbone and Their Hybridization with DNA: Interplay of Base Pairing and Electrostatic Attraction.
Schmidtgall B; Kuepper A; Meng M; Grossmann TN; Ducho C
Chemistry; 2018 Feb; 24(7):1544-1553. PubMed ID: 29048135
[TBL] [Abstract][Full Text] [Related]
40. Polymerase ribozyme efficiency increased by G/T-rich DNA oligonucleotides.
Yao C; Müller UF
RNA; 2011 Jul; 17(7):1274-81. PubMed ID: 21622900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
